Reduced stress- and cold-induced increase in energy expenditure in interleukin-6-deficient mice

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 291, Issue 3, 2006, Pages

  Wernstedt, Ingrid ^a,b   Edgley, Amanda ^c,d   Berndtsson, Anna ^a,b   Fäldt, Jenny ^a,b   Bergström, Göran ^c   Wallenius, Ville ^a,b   Jansson, John Olov ^a,b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d ASTRAZENECA R AND D   (Sweden)

Author keywords

Cytokine; Indirect calorimetry; Obesity; Telemetry

Indexed keywords

INTERLEUKIN 6;

ANIMAL EXPERIMENT; ARTICLE; BODY TEMPERATURE; CALORIMETRY; COLD EXPOSURE; CONTROLLED STUDY; CORE TEMPERATURE; ENERGY EXPENDITURE; ENERGY METABOLISM; EXERCISE TEST; HEART RATE; MALE; MOUSE; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN DEFICIENCY; ROOM TEMPERATURE; STRESS; TELEMETRY; THERMOGENESIS;

ANIMALS; COLD; ENERGY METABOLISM; FEMALE; INTERLEUKIN-6; MALE; MICE; MICE, KNOCKOUT; NOREPINEPHRINE; STRESS; THERMOGENESIS;

EID: 33748466547     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00514.2005     Document Type: Article

References (57)

1. Acalovschi D, Wiest T, Hartmann M, Farahmi M, Mansmann U, Auffarth GU, Grau AJ, Green FR, Grond-Ginsbach C, and Schwaninger M. Multiple levels of regulation of the interleukin-6 system in stroke. Stroke 34: 1864-1869, 2003.
2. Atrens DM, Sinden JD, Penicaud L, Devos M, and Le Magnen J. Hypothalamic modulation of energy expenditure. Physiol Behav 35: 15-20, 1985.
3. Bennermo M, Held C, Stemme S, Ericsson CG, Silveira A, Green F, and Tornvall P. Genetic predisposition of the interleukin-6 response to inflammation: implications for a variety of major diseases? Clin Chem 50: 2136-2140, 2004.
4. Berthier MT, Paradis AM, Tchernof A, Bergeron J, Prud'homme D, Despres JP, and Vohl MC. The interleukin 6-174G/C polymorphism is associated with indices of obesity in men. J Hum Genet 48: 14-19, 2003.
5. Carling D. The AMP-activated protein kinase cascade - a unifying system for energy control. Trends Biochem Sci 29: 18-24, 2004.
6. Chai Z, Gatti S, Toniatti C, Poli V, and Bartfai T. Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1 beta: a study on IL-6-deficient mice. J Exp Med 183: 311-316, 1996.
7. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 332: 1351-1362, 1995.
8. Consolazio CF, Johnson RE, and Pecora LJ. Physiological Measurements of Metabolic Functions in Man. New York: McGraw-Hill, 1963.
9. DeRuisseau LR, Parsons AD, and Overton JM. Adaptive thermogenesis is intact in B6 and A/J mice studied at thermoneutrality. Metabolism 53: 1417-1423, 2004.
10. Elhage R, Clamens S, Besnard S, Mallat Z, Tedgui A, Arnal J, Maret A, and Bayard F. Involvement of interleukin-6 in atherosclerosis but not in the prevention of fatty streak formation by 17β-estradiol in apolipoprotein E-deficient mice. Atherosclerosis 156: 315-320, 2001.
11. Escobar-Morreale HF, Calvo RM, Villuendas G, Sancho J, and San Millan JL. Association of polymorphisms in the interleukin 6 receptor complex with obesity and hyperandrogenism. Obes Res 11: 987-996, 2003.
12. Even PC, Mokhtarian A, and Pele A. Practical aspects of indirect calorimetry in laboratory animals. Neurosci Biobehav Rev 18: 435-447, 1994.
13. Faldt J, Wernstedt I, Fitzgerald SM, Wallenius K, Bergstrom G, and Jansson JO. Reduced exercise endurance in interleukin-6-deficient mice. Endocrinology 146: 2680-2686, 2004.
14. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, and Woo P. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102: 1369-1376, 1998.
15. Goldstein DS, Holmes C, Sharabi Y, Brentzel S, and Eisenhofer G. Plasma levels of catechols and metanephrines in neurogenic orthostatic hypotension. Neurology 60: 1327-1332, 2003.
16. Greenberg AS, Nordan RP, McIntosh J, Calvo JC, Scow RO, and Jablons D. Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin 6 in cancer cachexia. Cancer Res 52: 4113-4116, 1992.
17. Grouzmann E, Cavadas C, Grand D, Moratel M, Aubert JF, Brunner HR, and Mazzolai L. Blood sampling methodology is crucial for precise measurement of plasma catecholamines concentrations in mice. Pflügers Arch 447: 254-258, 2003.
18. Himms-Hagen J. On raising energy expenditure in ob/ob mice. Science 276: 1132-1133, 1997.
19. Illig T, Bongardt F, Schopfer A, Muller-Scholze S, Rathmann W, Koenig W, Thorand B, Vollmert C, Holle R, Kolb H, and Herder C. Significant association of the interleukin-6 gene polymorphisms C-174G and A-598G with type 2 diabetes. J Clin Endocrinol Metab 89: 5053-5058, 2004.
20. Kelly M, Keller C, Avilucea PR, Keller P, Luo Z, Xiang X, Giralt M, Hidalgo J, Saha AK, Pedersen BK, and Ruderman NB. AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exercise. Biochem Biophys Res Commun 320: 449-454, 2004.
21. Kenney MJ, Weiss ML, and Haywood JR. The paraventricular nucleus: an important component of the central neurocircuitry regulating sympathetic nerve outflow. Acta Physiol Scand 177: 7-15, 2003.
22. Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T, Zinkernagel R, Bluethmann H, and Kohler G. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368: 339-342, 1994.
23. Kozak W, Kluger MJ, Soszynski D, Conn CA, Rudolph K, Leon LR, and Zheng H. IL-6 and IL-1 beta in fever. Studies using cytokine-deficient (knockout) mice. Ann NY Acad Sci 856: 33-47, 1998.
24. Kubaszek A, Pihlajamaki J, Punnonen K, Karhapaa P, Vauhkonen I, and Laakso M. The C-174G promoter polymorphism of the IL-6 gene affects energy expenditure and insulin sensitivity. Diabetes 52: 558-561, 2003.
25. Lee DL, Leite R, Fleming C, Pollock JS, Webb RC, and Brands MW. Hypertensive response to acute stress is attenuated in interleukin-6 knockout mice. Hypertension 44: 259-263, 2004.
26. Leon LR, White AA, and Kluger MJ. Role of IL-6 and TNF in thermoregulation and survival during sepsis in mice. Am J Physiol Regul Integr Comp Physiol 275: R269-R277, 1998.
27. Li G, Klein RL, Matheny M, King MA, Meyer EM, and Scarpace PJ. Induction of uncoupling protein 1 by central interleukin-6 gene delivery is dependent on sympathetic innervation of brown adipose tissue and underlies one mechanism of body weight reduction in rats. Neuroscience 115: 879-889, 2002.
28. Lyngso D, Simonsen L, and Bulow J. Metabolic effects of interleukin-6 in human splanchnic and adipose tissue. J Physiol 543: 379-386, 2002.
29. Manfredi B, Sacerdote P, Gaspani L, Poli V, and Panerai AE. IL-6 knock-out mice show modified basal immune functions, but normal immune responses to stress. Brain Behav Immun 12: 201-211, 1998.
30. Marra M, Scalfi L, Covino A, Esposito-Del Puente A, and Contaldo F. Fasting respiratory quotient as a predictor of weight changes in non-obese women. Int J Obes Relat Metab Disord 22: 601-603, 1998.
31. Marz P, Cheng JG, Gadient RA, Patterson PH, Stoyan T, Otten U, and Rose-John S. Sympathetic neurons can produce and respond to interleukin 6. Proc Natl Acad Sci USA 95: 3251-3256, 1998.
32. Mohamed-Ali V, Flower L, Sethi J, Hotamisligil G, Gray R, Humphries SE, York DA, and Pinkney J. β-Adrenergic regulation of IL-6 release from adipose tissue: in vivo and in vitro studies. J Clin Endocrinol Metab 86: 5864-5869, 2001.
33. Morrow JD and Opp MR. Sleep-wake behavior and responses of interleukin-6-deficient mice to sleep deprivation. Brain Behav Immun 19: 28-39, 2005.
34. Nonogaki K, Fuller GM, Fuentes NL, Moser AH, Staprans I, Grunfeld C, and Feingold KR. Interleukin-6 stimulates hepatic triglyceride secretion in rats. Endocrinology 136: 2143-2149, 1995.
35. Ohlson KB, Lindahl SG, Cannon B, and Nedergaard J. Thermogenesis inhibition in brown adipocytes is a specific property of volatile anesthetics. Anesthesiology 98: 437-448, 2003.
36. Petersen EW, Carey AL, Sacchetti M, Steinberg GR, Macaulay SL, Febbraio MA, and Pedersen BK. Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro. Am J Physiol Endocrinol Metab 288: E155-E162, 2005.
37. Ravussin E and Swinburn BA. Metabolic predictors of obesity: cross-sectional versus longitudinal data. Int J Obes Relat Metab Disord 17 Suppl 3: S28-S31; discussion S41-S22, 1993.
38. Rivera-Chavez FA, Peters-Hybki DL, Barber RC, and O'Keefe GE. Interleukin-6 promoter haplotypes and interleukin-6 cytokine responses. Shock 20: 218-223, 2003.
39. Rothwell NJ. Central effects of CRF on metabolism and energy balance. Neurosci Biobehav Rev 14: 263-271, 1990.
40. Rothwell NJ, Busbridge NJ, Lefeuvre RA, Hardwick AJ, Gauldie J, and Hopkins SJ. Interleukin-6 is a centrally acting endogenous pyrogen in the rat. Can J Physiol Pharmacol 69: 1465-1469, 1991.
41. Seidell JC, Muller DC, Sorkin JD, and Andres R. Fasting respiratory exchange ratio and resting metabolic rate as predictors of weight gain: the Baltimore Longitudinal Study on Aging. Int J Obes Relat Metab Disord 16: 667-674, 1992.
42. Snitker S, Tataranni PA, and Ravussin E. Respiratory quotient is inversely associated with muscle sympathetic nerve activity. J Clin Endocrinol Metab 83: 3977-3979, 1998.
43. Stenlöf K, Wernstedt I, Fjällman T, Wallenius V, Wallenius K, and Jansson J. Interleukin-6 levels in the central nervous system are negatively correlated with fat mass in overweight/obese subjects. J Clin Endocrinol Metab 88: 4379-4383, 2003.
44. Stouthard JM, Romijn JA, Van der Poll T, Endert E, Klein S, Bakker PJ, Veenhof CH, and Sauerwein HP. Endocrinologic and metabolic effects of interleukin-6 in humans. Am J Physiol Endocrinol Metab 268: E813-E819, 1995.
45. Takaki A, Huang QH, Somogyvari-Vigh A, and Arimura A. Immobilization stress may increase plasma interleukin-6 via central and peripheral catecholamines. Neuroimmunomodulation 1: 335-342, 1994.
46. Terry CF, Loukaci V, and Green FR. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 275: 18138-18144, 2000.
47. Tsigos C, Papanicolaou DA, Kyrou I, Defensor R, Mitsiadis CS, and Chrousos GP. Dose-dependent effects of recombinant human interleukin-6 on glucose regulation. J Clin Endocrinol Metab 82: 4167-4170, 1997.
48. Turnbull AV, Prehar S, Kennedy AR, Little RA, and Hopkins SJ. Interleukin-6 is an afferent signal to the hypothalamo-pituitary-adrenal axis during local inflammation in mice. Endocrinology 144: 1894-1906, 2003.
49. Wallenius K, Wallenius VW, Sunter D, Dickson SL, and Jansson JO. Intracerebroventricular interleukin-6 treatment decreases body fat in rats. Biochem Biophys Res Commun 293: 560-565, 2002.
50. Wallenius V, Wallenius K, Ahrén B, Rudling M, Carlsten H, Dickson SL, Ohlsson C, and Jansson JO. Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 8: 75-79, 2002.
51. Vallieres L and Rivest S. Interleukin-6 is a needed proinflammatory cytokine in the prolonged neural activity and transcriptional activation of corticotropin-releasing factor during endotoxemia. Endocrinology 140: 3890-3903, 1999.
52. van Hall G, Steensberg A, Sacchetti M, Fischer C, Keller C, Schjerling P, Hiscock N, Moller K, Saltin B, Febbraio MA, and Pedersen BK. Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab 88: 3005-3010, 2003.
53. Webster EL, Torpy DJ, Elenkov IJ, and Chrousos GP. Corticotropinreleasing hormone and inflammation. Ann NY Acad Sci 840: 21-32, 1998.
54. Wernstedt I, Eriksson AL, Berndtsson A, Hoffstedt J, Skrtic S, Hedner T, Hulten LM, Wiklund O, Ohlsson C, and Jansson JO. A common polymorphism in the interleukin-6 gene promoter is associated with overweight. Int J Obes Relat Metab Disord 28: 1272-1279, 2004.
55. Wolford JK, Colligan PB, Gruber JD, and Bogardus C. Variants in the interleukin 6 receptor gene are associated with obesity in Pima Indians. Mol Genet Metab 80: 338-343, 2003.
56. Yang X, Jansson PA, Pellme F, Laakso M, and Smith U. Effect of the interleukin-6 (-174) g/c promoter polymorphism on adiponectin and insulin sensitivity. Obes Res 13: 813-817, 2005.
57. Zurlo F, Lillioja S, Esposito-Del Puente A, Nyomba BL, Raz I, Saad MF, Swinburn BA, Knowler WC, Bogardus C, and Ravussin E. Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ. Am J Physiol Endocrinol Metab 259: E650-E657, 1990.